© Reuters. Elevance Health earnings beat by $0.03, revenue fell short of estimates
Investing.com – Elevance Health (NYSE: ELV) reported fourth quarter EPS of $5.23, $0.03 better than the analyst estimate of $5.20. Revenue for the quarter came in at $39.67B versus the consensus estimate of $39.72B.
Guidance
Elevance Health sees FY 2023 EPS of $32.60 versus the analyst consensus of $32.69.
Elevance Health sees FY 2023 revenue of $164.00B versus the analyst consensus of $163.90B.
Elevance Health’s stock price closed at $478.52. It is down -11.98% in the last 3 months and up 11.69% in the last 12 months.
Elevance Health saw 3 positive EPS revisions and 16 negative EPS revisions in the last 90 days. See Elevance Health’s stock price’s past reactions to earnings here.
According to InvestingPro, Elevance Health’s Financial Health score is “great performance“.
Check out Elevance Health’s , and Elevance Health’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
Be the first to comment